Top Funds / PERCEPTIVE ADVISORS LLC


Joseph Edelman

2021Q1 Portfolio

SEC 13F Filing

Position #Shares $Value % # vs. 2020Q4 $ vs. 2020Q4
Mirati Therapeutics, Inc. 3,474,505 $595,183,000 7.51% -219,011 -$216,061,000
BridgeBio Pharma, Inc. 7,756,928 $477,827,000 6.03% +1,050,660 +$944,000
Retrophin, Inc. NOTE 2.500% 9/1 45,000,000 $474,750,000 5.99% No Change +$32,229,000
SpringWorks Therapeutics, Inc. 4,849,912 $356,808,000 4.50% +672,191 +$53,840,000
IOVANCE BIOTHERAPEUTICS, INC. 8,651,785 $273,915,000 3.46% -514,519 -$151,401,000
AMICUS THERAPEUTICS, INC. 22,861,329 $225,870,000 2.85% -2,250,719 -$353,967,000
BIOGEN INC. CALL 748,000 $209,253,000 2.64% New +$209,253,000
Global Blood Therapeutics, Inc. 5,058,642 $206,139,000 2.60% -616,069 -$39,632,000
Invitae Corp 5,360,673 $204,831,000 2.58% -1,923,793 -$99,732,000
COLLEGIUM PHARMACEUTICAL, INC NOTE 2.625% 2/1 17,500,000 $189,560,000 2.39% No Change +$16,310,000
Horizon Therapeutics Public Ltd Co 2,050,002 $188,682,000 2.38% -1,034,040 -$36,915,000
ATEA PHARMACEUTICALS INC 3,109,224 $184,693,000 2.33% No Change +$54,790,000
VBI Vaccines Inc/BC 55,042,465 $171,182,000 2.16% No Change +$19,816,000
BIOGEN INC. PUT 600,000 $167,850,000 2.12% New +$167,850,000
LANDOS BIOPHARMA INC 17,960,839 $159,688,000 2.01% New +$159,688,000
Zymeworks Inc. 4,330,868 $136,769,000 1.73% +29,869 -$66,496,000
NEVRO CORP NOTE 2.750% 4/0 9,000,000 $135,324,000 1.71% No Change -$30,096,000
OUTSET MED INC 2,387,535 $129,858,000 1.64% -460,287 -$32,012,000
ROCKET PHARMACEUTICALS, INC. 2,867,771 $127,243,000 1.60% -529,096 -$59,041,000
C4 THERAPEUTICS INC STK 3,158,566 $116,835,000 1.47% No Change +$12,192,000
NEVRO CORP 812,154 $113,295,000 1.43% -165,411 -$55,922,000
Aldeyra Therapeutics, Inc. 8,703,879 $103,402,000 1.30% +2,418,421 +$60,284,000
MeiraGTx Holdings plc 6,933,277 $93,374,000 1.18% No Change -$11,596,000
NEUROCRINE BIOSCIENCES INC 941,832 $91,593,000 1.16% -957,383 -$90,447,000
Alector, Inc. 2,360,139 $83,195,000 1.05% No Change -$5,334,000